Dengue Vaccination
Cross-source consensus on Dengue Vaccination from 1 sources and 6 claims.
1 sources · 6 claims
Uses
Preparation
Risks & contraindications
Comparisons
Evidence quality
Highlighted claims
- Vaccination is presented as a supplementary rather than primary dengue management tool. — Towards an integrated model for dengue management: a scoping review
- Dengvaxia was used cautiously because it poses risks for seronegative individuals. — Towards an integrated model for dengue management: a scoping review
- Access, financing, and large-scale rollout of dengue vaccines remain constrained, especially in low- and middle-income countries. — Towards an integrated model for dengue management: a scoping review
- Pre-vaccination antibody screening was introduced in several countries to reduce severe dengue risk in people without prior exposure. — Towards an integrated model for dengue management: a scoping review
- TAK-003 received WHO endorsement for programmatic use under defined conditions. — Towards an integrated model for dengue management: a scoping review
- TV005 and mRNA dengue vaccine candidates are still under development. — Towards an integrated model for dengue management: a scoping review